Beyond the Ticker

2stories

28 Aprlast updated

Has Rescheduling Accelerated the Cannabis M&A Wave?

Last week’s rescheduling announcement has placed a spotlight firmly on the medical cannabis arms of North America’s largest operators.

Ben Stevens28 April 2026

Clinical Research

Evidence, Earnings and Expansion: Avextra Enrolls its First Patient to Landmark Italian Clinical Trial, as Market Leaders Wrangle to Maintain Dominance

30 October 2025